IGS firm wins patent lawsuit

Article

BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems, has prevailed in its patent battle with Nomos. BrainLAB announced Feb. 9 that the U.S. Court of Appeals for the Federal Circuit in Washington, DC, has upheld a

BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems, has prevailed in its patent battle with Nomos. BrainLAB announced Feb. 9 that the U.S. Court of Appeals for the Federal Circuit in Washington, DC, has upheld a lower court ruling that BrainLAB's ExacTrac product does not infringe U.S. patent 5,411,026 for Nomos' BAT ultrasound-based target locating device. ExacTrac is BrainLAB's patient positioning system for the treatment of tumors with stereotactic radiotherapy/radiosurgery. The system's ultrasound localization allows a daily verification of the position of organs, such as the prostate or liver, which improves the precision of radiotherapy by allowing adjustments for shifts in organ position.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.